The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Magnetic Resonance Imaging Safety in Pregnancy

Evidence-Based Approach to MRI Use During Pregnancy with Maternal-Fetal Considerations

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Kadın Hastalıkları ve Doğum department. Book Appointment →

What is Magnetic Resonance Imaging Safety in Pregnancy?

MRI uses strong magnetic fields, gradient coils, and radiofrequency pulses to generate detailed cross-sectional images without ionizing radiation, making it an attractive alternative to CT during pregnancy.

Major medical organizations (ACR, ACOG, RCOG) endorse MRI use during pregnancy when clinically indicated, with evidence supporting safety at 1.5T and 3T field strengths.

Common indications during pregnancy: maternal neurological symptoms (suspected stroke, seizure, hydrocephalus), abdominal pain (appendicitis, biliary disease), pelvic mass, suspected fetal abnormalities (CNS, abdominal, thoracic), placental abnormalities (placenta accreta spectrum, abruption).

Theoretical concerns about MRI in pregnancy include heating effects (specific absorption rate, SAR), acoustic noise, and contrast agent effects; current evidence supports safety with appropriate protocol selection.

Symptoms

Indications: clinical evaluation of suspected maternal or fetal pathology when alternative non-radiation imaging (ultrasound) is non-diagnostic
Maternal indications: persistent abdominal pain, neurological symptoms, suspicion of malignancy, evaluation of pelvic mass not characterized by ultrasound
Obstetric indications: detailed evaluation of suspected placental abnormalities (placenta accreta, percreta, increta), assessment of complex fetal anomalies (CNS abnormalities, congenital diaphragmatic hernia, sacrococcygeal teratoma), suspected uterine rupture, complications of multiple pregnancy
Fetal indications: characterization of brain anomalies seen on ultrasound, detailed cardiac assessment in select cases, body anomalies poorly visualized by ultrasound
Most pregnant women tolerate MRI well; some experience claustrophobia, especially in third trimester

Risk Factors

Theoretical risks (not consistently demonstrated): potential heating effects (SAR), especially with longer scans and higher field strength; acoustic noise (ear protection mitigates); contrast agent effects
Gadolinium contrast: crosses placenta and can persist in fetal compartment and amniotic fluid; FDA category C with limited human data; recommended to avoid in pregnancy unless absolutely necessary
Ferromagnetic implants: cardiac pacemakers, intracranial aneurysm clips, cochlear implants — patient screening required
Pregnancy stage considerations: most concerns relate to first trimester organogenesis (theoretical), although evidence supports safety at all gestational ages
Maternal anxiety, claustrophobia, or inability to lie supine for prolonged periods (large gravid uterus in third trimester)
ACR and ACOG guidelines: MRI without contrast is generally safe in pregnancy when indicated and not deferable until after delivery

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Pregnant woman with clinical indication for advanced imaging not adequately addressed by ultrasonography
  • Suspected maternal stroke, intracranial hemorrhage, or other neurological emergency
  • Acute abdominal pain in pregnancy with non-diagnostic ultrasound (suspected appendicitis, biliary disease)
  • Complex fetal anomalies on ultrasonography requiring further characterization
  • Suspected placental abnormality (placenta accreta spectrum) for delivery planning
  • Counseling for pregnant patient about MRI safety and alternative imaging options

Treatment Methods

01
Pre-procedure evaluation: review of clinical indication, consideration of alternative imaging (ultrasonography first-line for many indications), gestational age, patient comfort and ability to remain still, screening for ferromagnetic implants
02
Counseling: discuss safety profile, expected scan duration (30–60 minutes typical), positioning options (lateral decubitus may be needed in third trimester for caval compression), claustrophobia management
03
Field strength selection: 1.5T strongly preferred over 3T due to lower SAR and reduced heating effects, especially for longer scans; both are considered safe with appropriate protocols
04
Specific Absorption Rate (SAR) limits: standard SAR limits should be respected; use of low-SAR sequences when possible, particularly in first trimester and for longer scans
05
Acoustic noise: hearing protection (earplugs or headphones) for the mother; theoretical fetal noise exposure limited by maternal abdominal attenuation
06
Maternal positioning: supine position is generally tolerated; lateral decubitus may be necessary in third trimester to relieve caval compression and improve maternal comfort
07
Gadolinium contrast: avoid in pregnancy when possible; use only when absolutely necessary for diagnostic accuracy; if used, prefer macrocyclic agents and lowest necessary dose; counsel about theoretical risks and uncertainty
08
Specific protocol considerations: optimize sequences for diagnostic yield while minimizing scan time; use rapid imaging techniques (single-shot fast spin echo, EPI); fetal MRI typically uses single-shot techniques for motion mitigation
09
Fetal MRI interpretation: typically performed at 18+ weeks for anatomic detail; specialized expertise required for pediatric/fetal radiology; multidisciplinary review with maternal-fetal medicine, neonatology, pediatric surgery as appropriate
10
Post-procedure follow-up: clinical assessment if any symptoms during scan, communication of findings, discussion of management implications, multidisciplinary planning for delivery and postnatal care
11
Documentation: indication, MRI findings, gadolinium use (if any), counseling discussion in medical record
12
Patient education materials: provided pre-scan information about MRI safety, what to expect during scan, post-scan considerations; reassurance about evidence-based safety of MRI without contrast
13
Quality and safety assurance: MRI safety officer review, adherence to institutional MRI safety protocols, education of MRI staff about pregnancy-specific considerations

Which Department to Visit?

You can visit our Kadın Hastalıkları ve Doğum department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Kadın Hastalıkları ve Doğum Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Regular Gynecological Check-up

Kadın Hastalıkları ve Doğum

Regular gynecological check-ups enable early diagnosis of many women's diseases and increase treatment success. It is recommended that every sexually active woman or woman over 21 see a gynecologist at least once a year.

Cervical Cancer

Kadın Hastalıkları ve Doğum

Cervical cancer develops from uncontrolled growth of cells in the cervix and is among the most common women's cancers worldwide. Precancerous lesions can be recognized with regular Pap smear and HPV testing.

HPV and Vaccination

Kadın Hastalıkları ve Doğum

HPV is a common virus transmitted sexually that can lead to certain types of cancer. Vaccination provides over 90% protection against high-risk HPV strains.

Ovarian Cyst

Kadın Hastalıkları ve Doğum

Ovarian cysts are fluid-filled sacs that form in or on the ovarian tissue. Most are asymptomatic and disappear spontaneously; however, large or complex cysts can cause pain and complications.

Endometriosis

Kadın Hastalıkları ve Doğum

Endometriosis affects about 10% of women of reproductive age, causing cyclic pelvic pain, dysmenorrhea, dyspareunia, and infertility; combined medical and laparoscopic treatment improves quality of life.

Uterine Fibroids

Kadın Hastalıkları ve Doğum

Uterine fibroids are benign tumors developing from the uterine muscle layer. They affect 20-50% of women of reproductive age; most are asymptomatic, but can cause bleeding and pain.

Polycystic Ovary Syndrome (PCOS)

Kadın Hastalıkları ve Doğum

PCOS is the most common endocrine disease affecting approximately 10% of women of reproductive age, characterized by androgen excess, ovulation disorder, and polycystic ovarian appearance.

Menopause

Kadın Hastalıkları ve Doğum

Menopause is the life stage defined by not having a period for 12 consecutive months and the natural cessation of ovarian function. The average age is 51, but it can vary between 45-55 years.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.